Sloan-Kettering Institute for Cancer Research;Aragon Pharmaceuticals, Inc.
发明人:
Smith, Nicholas D.,Herbert, Mark R.,Ouerfelli, Ouathek,Dilhas, Anna
申请号：
HRP20180902
公开号：
HRP20180902T1
申请日:
2018.06.11
申请国别(地区):
HR
年份:
2018
代理人:
摘要：
Described herein are crystalline forms of the androgen receptor modulated 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3,4]oct-5-yl]-2-fluoro-N-methylbenzamide, pharmaceutically acceptable salts, solvates, as well as pharmaceutical compositions thereof, and the same for use in treatment or prevention of diseases or conditions associated with androgen receptor activity.
